对于早期乳腺癌的SEOM-GEICAM-SOLTI临床指南 (2022)
Francisco Ayala de la Peña1, Silvia Antolín Novoa2, Joaquín Gavilá Gregori3
1Department of Medical Oncology, Hospital G. Universitario Morales Meseguer, University of Murcia, Av. Marqués de los Vélez, s/n, 30008, Murcia, Spain. frayala@um.es.
概括
这份临床实践指南涉及西班牙乳腺癌,这对女性来说是一个日益关注的问题. 它审查新的诊断工具和免疫疗法等疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 临床实践指南 临床实践指南
- 妇女健康 妇女健康
背景情况:
- 乳腺癌是西班牙妇女中最常见的癌症,发病率正在上升.
- 查程序在早期,可治疗的阶段检测到大约90%的病例.
- COVID-19大流行对查和诊断的影响需要进一步量化.
研究的目的:
- 为西班牙乳腺癌管理提供最新的临床实践指南.
- 整合最近的诊断工具和治疗策略的进展.
- 为最佳的患者护理提供基于专家共识的建议.
主要方法:
- 对相关科学研究进行系统审查.
- 在GEICAM,SOLTI和SEOM的专家之间建立共识.
- 评估新的诊断工具和治疗策略,包括免疫疗法,向药物和抗体药物合物.
主要成果:
- 诊断工具的进步提高了治疗毒性和临床益处之间的平衡.
- 新兴疗法,如免疫疗法和抗体-药物合物,在特定的患者亚组中显示出改善的结果.
- 这些指导方针反映了局部区域和全身疗法的最新证据.
结论:
- 该指南包含了新的治疗策略,以改善乳腺癌患者的治疗结果.
- 它强调了在临床实践中更新诊断和治疗方法的重要性.
- 建议旨在基于专家共识和系统审查,优化西班牙的乳腺癌护理.
相关概念视频
Standards of Care II
689
Nurses bear specific legal responsibilities under several federal statutes, including:
689
Standards of Care I
731
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
731
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K


